```html

Quasi‑syncope: A Comprehensive Medical Guide

Overview

Quasi‑syncope (also called “near‑syncope” or “presyncope”) describes a set of symptoms that feel like fainting but do not result in a loss of consciousness. People experience light‑headedness, dizziness, visual changes, or a sensation of “almost” passing out, yet they remain awake and aware.

Quasi‑syncope can affect anyone, but it is most common in:

• Adults aged 40–70 years
• Women (particularly those with anemia or hormonal fluctuations)
• Individuals with underlying cardiovascular, neurologic, or metabolic disorders

According to the American Heart Association, about 6 % of the adult population reports at least one episode of presyncope each year, and up to 15 % of emergency‑department visits for “fainting” are ultimately classified as quasi‑syncope after work‑up.<sup>[1]</sup>

Symptoms

Quasi‑syncope is a symptom complex rather than a disease. The typical manifestations include:

Neurological sensations

• Dizziness or vertigo – a spinning sensation or feeling “off‑balance.”
• Light‑headedness – a sense that the room is moving or that you might lose consciousness.
• Blurred or “tunnel” vision – loss of peripheral vision, sometimes called “graying out.”
• Auditory changes – ringing in the ears (tinnitus) or muffled hearing.

Cardiovascular symptoms

• Palpitations – awareness of a rapid, irregular, or “fluttering” heartbeat.
• Chest discomfort – mild pressure or tightness (often non‑cardiac).
• Cold, clammy skin – especially on the extremities.
• Pulsatile tinnitus – hearing a heartbeat in the ears.

Autonomic signs

• Nausea or abdominal discomfort
• Weakness or fatigue – often improves quickly after sitting or lying down.
• Shortness of breath – especially when standing quickly.

Triggers

• Standing for prolonged periods
• Sudden posture changes (e.g., standing up quickly)
• Dehydration or overheating
• Emotional stress, anxiety, or pain
• Medications that lower blood pressure (e.g., antihypertensives, diuretics)

Causes and Risk Factors

Quasi‑syncope results when blood flow to the brain temporarily declines, but not enough to cause a full loss of consciousness. The underlying mechanisms fall into several categories.

1. Cardiovascular causes

• Orthostatic hypotension – a drop in systolic BP ≥20 mm Hg or diastolic BP ≥10 mm Hg within 3 minutes of standing.<sup>[2]</sup>
• Cardiac arrhythmias – bradyarrhythmias (e.g., sinus node dysfunction) or tachyarrhythmias (e.g., atrial fibrillation) that reduce cardiac output.
• Valvular heart disease – especially aortic stenosis or severe mitral regurgitation.
• Heart failure – decreased forward flow, especially during exertion.

2. Reflex (neurally‑mediated) mechanisms

• Vasovagal (neurally mediated) syncope – triggered by pain, fear, or prolonged standing; characterized by bradycardia and vasodilation.
• Carotid sinus hypersensitivity – pressure on the carotid sinus (e.g., tight collar) causing reflex bradycardia.
• Situational syncope – coughing, urination, or swallowing causing vagal stimulation.

3. Metabolic and hematologic factors

• Hypoglycemia – low blood glucose (<70 mg/dL) especially in diabetic patients on insulin or sulfonylureas.
• Anemia – reduced oxygen‑carrying capacity, common in women of childbearing age.
• Electrolyte disturbances – hypokalemia, hyponatremia, or hypercalcemia affecting vascular tone.

4. Medications

• Antihypertensives (ACE inhibitors, calcium‑channel blockers)
• Diuretics (especially loop diuretics)
• Beta‑blockers
• Antidepressants (tricyclics, SSRIs) that cause autonomic instability

Risk factors

• Age > 65 years (autonomic regulation wanes)
• Female sex (lower baseline BP and higher prevalence of anemia)
• Dehydration or high‑heat environments
• Prolonged bed rest or immobility
• Chronic illnesses: diabetes, Parkinson’s disease, chronic kidney disease

Diagnosis

Diagnosing quasi‑syncope is largely a process of exclusion – confirming that a true loss of consciousness has not occurred while searching for the underlying trigger.

Step‑by‑step clinical approach

1. Detailed history – type and duration of symptoms, precipitating factors, medication list, past medical history, family history of arrhythmias or sudden death.
2. Physical examination – orthostatic vital signs (supine, sitting, standing), cardiac auscultation, neurologic screen.
3. Basic laboratory studies – CBC (to rule out anemia), fasting glucose, electrolytes, BUN/creatinine, thyroid‑stimulating hormone.
4. Electrocardiogram (ECG) – to detect arrhythmias, conduction blocks, QT prolongation.
5. Holter monitoring or event recorder – 24‑48 h (or longer) recordings for intermittent arrhythmias.
6. Tilt‑table test – reproduces orthostatic or vasovagal responses under controlled conditions.
7. Echocardiography – assesses cardiac structure, ejection fraction, valvular disease.
8. Carotid sinus massage – performed only in a monitored setting to evaluate carotid hypersensitivity.
9. Neurologic imaging (CT/MRI) – rarely needed unless focal neurologic signs appear.

Guidelines from the American College of Cardiology (ACC) and the European Society of Cardiology (ESC) emphasize that orthostatic vital signs are essential; failure to obtain them can miss up to 30 % of orthostatic hypotension cases.<sup>[3]</sup>

Treatment Options

Treatment targets the identified cause and alleviates symptoms. In many cases, a combination of medication adjustment, lifestyle modification, and targeted therapy is required.

1. Medication adjustments

• Review antihypertensives – lower the dose or switch to a shorter‑acting agent if orthostatic drops are present.
• Fludrocortisone (0.1 mg‑0.2 mg daily) – mineralocorticoid that expands plasma volume, useful for orthostatic hypotension.
• Midodrine (2.5 mg‑10 mg TID) – an α‑agonist that raises standing BP; contraindicated in severe hypertension.
• Iron supplementation – oral ferrous sulfate or IV iron for documented iron‑deficiency anemia.
• Carbohydrate‑rich snacks – for patients with hypoglycemia‑related near‑syncope.

2. Procedural interventions

• Pacemaker implantation – indicated for refractory cardio‑inhibitory vasovagal syncope or significant bradyarrhythmias.
• Catheter ablation – for recurrent supraventricular tachycardia causing presyncope.
• Compression stockings (graded 30‑40 mm Hg) – reduce venous pooling in the lower limbs.

3. Lifestyle and non‑pharmacologic measures

• Increase fluid intake to ≥ 2–3 L/day (salt‑free water for patients without heart failure).
• Increase dietary sodium by 500–1000 mg/day if not contraindicated.
• Rise slowly from supine or seated positions; pause for 1–2 minutes before standing fully.
• Engage in regular, moderate‑intensity aerobic exercise (e.g., walking 30 min most days) to improve autonomic tone.
• Avoid prolonged standing; if unavoidable, shift weight from one foot to the other or flex calf muscles.
• Wear body‑compression garments (abdominal binders) during long trips or hot weather.
• Manage triggers – apply stress‑reduction techniques (deep breathing, mindfulness) for vasovagal episodes.

Living with Quasi‑syncope

While quasi‑syncope is rarely life‑threatening, it can impair quality of life, cause anxiety, and limit daily activities. Below are practical tips for patients and caregivers.

Self‑monitoring

• Keep a symptom diary noting time of day, position, activity, fluid/food intake, and medications.
• Use a home blood pressure monitor to track supine and standing readings; a drop of >20 mm Hg warrants discussion with a provider.

Work and travel

• Request an ergonomic workstation that allows sitting and occasional standing.
• When flying, stay hydrated, move ankles frequently, and wear compression socks.
• Carry a small water bottle, salty snack, and a list of emergency contacts.

Driving safety

Most patients can drive safely if episodes are infrequent and well controlled. However, those with unexplained or frequent near‑syncope should discuss driving privileges with their physician and may need a temporary restriction.

Emotional health

Episodes can provoke fear of falling. Cognitive‑behavioral therapy (CBT) or counseling can help reduce anxiety and improve coping strategies.<sup>[4]</sup>

Prevention

Prevention revolves around controlling modifiable risk factors and maintaining good cardiovascular health.

• Hydration – Aim for 2–3 L of fluid daily; adjust upward in hot climates or during exercise.
• Balanced diet – Adequate iron (red meat, beans, fortified cereals) and electrolytes (potassium, magnesium).
• Medication review – Annual reconciliation with a pharmacist or clinician.
• Physical conditioning – Strengthening lower‑extremity muscles improves venous return.
• Temperature control – Avoid hot baths, saunas, or prolonged exposure to high heat.
• Stress management – Regular relaxation techniques (progressive muscle relaxation, yoga).

Complications

Although quasi‑syncope itself does not cause permanent damage, untreated underlying conditions may lead to serious outcomes:

• Falls and injuries – Particularly in the elderly; can result in fractures or head trauma.
• Cardiac events – Undiagnosed arrhythmias may progress to syncope, cardiac arrest, or heart failure.
• Ischemic brain injury – Repeated cerebral hypoperfusion can contribute to cognitive decline over years.
• Reduced quality of life – Chronic anxiety, activity avoidance, and social isolation.

When to Seek Emergency Care

---

References

1. American Heart Association. “Syncope and Near‑Syncope.” 2023. heart.org.
2. Mayo Clinic. “Orthostatic Hypotension.” Updated 2022. mayoclinic.org.
3. European Society of Cardiology. “Guidelines for the Diagnosis and Management of Syncope.” Eur Heart J. 2022;43:2634‑2692.
4. Cleveland Clinic. “Psychological Impact of Recurrent Syncope.” 2021. clevelandclinic.org.

```